XTL Biopharmaceuticals Ltd Net Asset Quality Index
XTL Biopharmaceuticals Ltd net asset quality index. XTL Biopharmaceuticals Ltd (XTLB) has a Net Asset Quality Index of 63.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA8.55 Million minus total liabilities of ILA3.12 Million yields net assets of ILA5.43 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of XTL Biopharmaceuticals Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of XTL Biopharmaceuticals Ltd (2013–2024)
Net asset quality index of XTL Biopharmaceuticals Ltd from 2013 to 2024. This chart shows how XTL Biopharmaceuticals Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of December 2024, the index stands at 63.6%, representing net assets of ILA5.43 Million against total assets of ILA8.55 Million ILA. Check XTLB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
XTL Biopharmaceuticals Ltd Net Asset Quality Index by Year (2013–2024)
XTL Biopharmaceuticals Ltd net asset quality index by year from 2013 to 2024. The table below presents the year-by-year Net Asset Quality Index for XTL Biopharmaceuticals Ltd from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XTLB stock market capitalisation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 63.6% | ILA5.43 Million | ILA8.55 Million | ILA3.12 Million | ▼ -27.9 pp |
| 2023 | 91.5% | ILA2.22 Million | ILA2.43 Million | ILA206.00K | ▼ -4.0 pp |
| 2022 | 95.5% | ILA4.00 Million | ILA4.19 Million | ILA187.00K | ▲ +14.9 pp |
| 2021 | 80.6% | ILA5.33 Million | ILA6.62 Million | ILA1.28 Million | ▼ -15.5 pp |
| 2020 | 96.1% | ILA6.25 Million | ILA6.50 Million | ILA254.00K | ▼ -0.7 pp |
| 2019 | 96.8% | ILA6.98 Million | ILA7.21 Million | ILA232.00K | ▼ -0.3 pp |
| 2018 | 97.0% | ILA8.32 Million | ILA8.57 Million | ILA253.00K | ▲ +42.1 pp |
| 2017 | 54.9% | ILA3.62 Million | ILA6.59 Million | ILA2.97 Million | ▼ -34.1 pp |
| 2016 | 89.1% | ILA2.69 Million | ILA3.02 Million | ILA330.00K | ▼ -2.7 pp |
| 2015 | 91.8% | ILA4.89 Million | ILA5.32 Million | ILA436.00K | ▲ +8.9 pp |
| 2014 | 82.9% | ILA4.68 Million | ILA5.64 Million | ILA965.00K | ▼ -1.8 pp |
| 2013 | 84.7% | ILA6.79 Million | ILA8.02 Million | ILA1.23 Million | — |